Clinical Trial Update: Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating local injection of Botulinum toxin Type B for digital ulcers in systemic sclerosis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Botulinum toxin Type B (botulinum toxin type B)

Snippet

Sponsor: Gunma University | Conditions: Systemic Sclerosis Patients With Digital Ulcers | Phase 2 | Status: COMPLETED